Phico Therapeutics Ltd. Alternatives & Competitors
12 companies similar to Phico Therapeutics Ltd. — Phico Therapeutics is a biotechnology company advancing the war on antibiotic re...
Companies similar to Phico Therapeutics Ltd.
Tetraphase Pharmaceuticals
Fighting against antimicrobial resistance is at the core of our technology and our people.
Venatorx Pharmaceuticals, Inc.
Discovering & developing novel anti-infectives to treat multi-drug resistant bacterial & h...
Adaptive Phage Therapeutics
To save lives or restore health as a leader in safe, rapidly deployable, cost-effective cu...
Curza
Small molecule therapeutics R&D company focused on developing new drugs to combat antibiot...
Rival Readout
Competing with Phico Therapeutics Ltd.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Zikani Therapeutics
A new era in antibiotic treatment targeting resilient gram-negative bacteria, delivering a...
Prokaryotics, Inc.
Antibacterial discovery organization committed to bringing forth innovative therapeutics t...
Qpex Biopharma
Focusing on Resistance in Antibiotic Development
Recce Pharmaceuticals Ltd
Recce Pharmaceuticals (ASX:RCE) is pioneering a New Class of Synthetic Anti-Infectives to...
MGB Biopharma Limited
Delivering Novel Anti-Infectives
Trobix Bio
PIONEERING PRECISION HUMAN MICROBIOME THERAPEUTICS
Matrubials Inc.
Developing milk-inspired therapies for infectious diseases
Akthelia Pharmaceuticals
Modulating innate immunity to improve cancer therapy outcomes. .
About Phico Therapeutics Ltd.
Phico Therapeutics Ltd. is a biotechnology company committed to combatting antibiotic resistance through engineered phage therapy. Founded in 2000 and headquartered in the United Kingdom, the company strategically positions itself within the Biopharma, Biotechnology, Health Care, and Pharmaceutical industries.
Phage Therapy, Antibiotic Resistance, Superbugs, Antibacterial Protein, SASP Technology, SASPject, Antimicrobial Resistance, Multi-drug Resistant Bacteria, Antibiotic Development, Engineered Phages, Bacterial DNA Inactivation, Next-generation Antibiotics, Novel Platform Technology
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Phico Therapeutics Ltd.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Phico Therapeutics Ltd. on 11 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.